Another meta‐analysis has shown that loss of RB1 function leads to a 1.6 two‐fold increase in the mortality of patients with osteosarcoma, a significant increase in osteosarcoma metastasis, and a notable decrease in osteosarcoma response to chemotherapy.24 The gene discussed is RB1; the disease is osteosarcoma.